Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-alpha-2a. [electronic resource]
- Antiviral research Jan 2009
- 88-91 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-9096
10.1016/j.antiviral.2008.09.005 doi
Adenine--analogs & derivatives Adult Antiviral Agents--therapeutic use Female Hepatitis B Antigens--blood Hepatitis B virus--drug effects Hepatitis B, Chronic--drug therapy Humans Interferon alpha-2 Interferon-alpha--therapeutic use Male Middle Aged Organophosphonates--therapeutic use Polyethylene Glycols--therapeutic use Recombinant Proteins Viral Load